— Know what they know.
Not Investment Advice
Also trades as: VIRP.PA (PAR) · $vol 2M

VRBCF OTC

Virbac S.A.
1W: +0.0% 1M: +0.0% 3M: -5.7% YTD: +10.8% 1Y: +10.8% 3Y: -3.4% 5Y: +14.1%
$383.25
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 37 · $3.2B mcap · 4M float · 0.0000% daily turnover · Short 73% of daily vol

Income Trends

Revenue
$1.5B +4.8% ▲
5Y CAGR: +9.4%
Gross Profit
$518M -44.8% ▼
5Y CAGR: -3.5%
Operating Income
$218M -4.1% ▼
5Y CAGR: +3.5%
Net Income
$151M +3.8% ▲
5Y CAGR: +2.1%
EPS (Diluted)
$17.98 +3.7% ▲
5Y CAGR: +2.2%
EBITDA
$278M +0.6% ▲
5Y CAGR: +11.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$1.1B$1.2B$1.2B$1.4B$1.5B
YoY Growth+13.9%+14.3%+2.5%+12.1%+4.8%
Cost of Revenue$351M$421M$437M$460M$946M
Gross Profit$713M$795M$810M$938M$518M
Gross Margin67.0%65.4%64.9%67.1%35.4%
R&D Expenses$0$0$0$0$0
SG&A Expenses$203M$240M$0$0$281M
Operating Expenses$546M$613M$625M$710M$300M
Operating Income$168M$180M$185M$227M$218M
Operating Margin15.8%14.8%14.8%16.3%14.9%
Interest Expense$6M$4M$9M$12M$9M
Income Before Tax$159M$177M$175M$208M$218M
Tax Expense$44M$56M$54M$62M$67M
Net Income$113M$122M$121M$145M$151M
Net Margin10.6%10.0%9.7%10.4%10.3%
EPS (Diluted)$13.40$14.43$14.38$17.34$17.98
EBITDA$208M$218M$231M$276M$278M
Shares Outstanding8M8M8M8M8M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms